Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 3/20 | 0.70 |
| ▸ | CYP11B1 | P15538 | 2/20 | 0.50 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.50 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.50 |
| ▸ | HRH3 | Q9Y5N1 | 7/20 | 0.49 |
| ▸ | CSNK1D | P48730 | 4/20 | 0.45 |
| ▸ | CSNK1G2 | P78368 | 3/20 | 0.45 |
| ▸ | CSNK1A1 | P48729 | 1/20 | 0.45 |
| ▸ | GSK3B | P49841 | 1/20 | 0.45 |
| ▸ | CCR9 | P51686 | 1/20 | 0.43 |
| ▸ | PGR | P06401 | 1/20 | 0.43 |
| ▸ | PTPN5 | P54829 | 1/20 | 0.39 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18118556 | 0.90 | KIF11 (0.70) | KIF11CYP11B1CYP11B2CYP17A1HRH3 | |
| SCHEMBL19798867 | 0.85 | KIF11 (0.57) | KIF11CYP11B1CYP11B2CYP17A1CSNK1D | |
| SCHEMBL3421538 | 0.83 | KIF11 (1.00) | KIF11CYP11B2CSNK1DCSNK1G2CSNK1A1 | |
| SCHEMBL3420933 | 0.83 | KIF11 (1.00) | KIF11CYP11B2CSNK1DCSNK1G2CSNK1A1 | |
| SCHEMBL25708841 | 0.81 | KIF11 (0.53) | KIF11CYP11B1CYP11B2CYP17A1HRH3 | |
| SCHEMBL13761675 | 0.81 | KIF11 (0.67) | KIF11PGRPTPN5 | |
| SCHEMBL24617134 | 0.81 | KIF11 (0.79) | KIF11CYP11B2HRH3PTPN5EPHX2 | |
| SCHEMBL13350234 | 0.80 | ALDH1A1 (0.56) | KIF11CYP11B1CYP11B2CYP17A1HRH3 | |
| SCHEMBL19656644 | 0.80 | KIF11 (0.55) | KIF11CYP11B1CYP11B2CSNK1DCSNK1G2 | |
| SCHEMBL5477144 | 0.79 | CYP11B1 (0.61) | CYP11B1CYP11B2CYP17A1HRH3PGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220220084-A1 | ORGANIC COMPOUND, ELECTRONIC COMPONENT AND ELECTRONIC APPARATUS | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2022-07-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220220084-A1 | ORGANIC COMPOUND, ELECTRONIC COMPONENT AND ELECTRONIC APPARATUS | EXOC4, CYBA, SCO2 | KIF11 3243/4885CYP11B1 1032/4885CYP11B2 495/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.